Radboudumc Center of Expertise for Cancer Survivorship, Department of Hematology, Radboud University Medical Center, Nijmegen, the Netherlands.
Department of Pediatric Oncology/Hematology, VU University, Amsterdam University Medical Centers, Amsterdam, the Netherlands.
Cancer. 2022 Mar 1;128(5):1110-1121. doi: 10.1002/cncr.33993. Epub 2021 Nov 1.
Cancer-related fatigue is a debilitating late effect after treatment for childhood cancer. The prevalence of fatigue in childhood cancer survivors (CCSs) and associated factors for fatigue has varied widely in previous studies. Two important aspects of cancer-related fatigue, its severity and chronicity, are often not assessed. This study investigated the prevalence of, and risk factors for, severe chronic fatigue (CF) in a national cohort of Dutch CCSs.
In this study, 2810 CCSs (5-year survivors of all childhood malignancies diagnosed between 1963 and 2001 with a current age of 12-65 years) and 1040 sibling controls were included. CF was assessed with the Short Fatigue Questionnaire and was defined as a score ≥ 18 and persistence of fatigue for ≥6 months. Cancer- and treatment-related characteristics, current health problems, and demographic and lifestyle variables were assessed as potential risk factors for CF via multivariable logistic regression analyses.
In adult CCSs and sibling controls (≥18 years old), the prevalence of CF was 26.1% and 14.1%, respectively (P < .001). In adolescent CCSs and sibling controls (<18 years old), the prevalence of CF was 10.9% and 3.2%, respectively. Female gender (odds ratio [OR], 2.13; 95% confidence interval [CI], 1.73-2.62), unemployment (OR, 2.18; 95% CI, 1.67-2.85), having 1 or more health problems (OR for 1-2, 1.48; 95% CI, 1.18-1.87; OR for >2, 2.20; 95% CI, 1.50-3.21), and a central nervous system diagnosis (OR, 1.74; 95% CI, 1.17-2.60) were significantly associated with CF in adult CCSs.
This study shows that CCSs, regardless of their cancer diagnosis, report CF more often than sibling controls. This study provides new evidence for the prevalence of fatigue in CCSs.
癌症相关疲劳是儿童癌症治疗后的一种使人虚弱的晚期效应。在之前的研究中,儿童癌症幸存者(CCS)中疲劳的患病率及其相关因素差异很大。癌症相关疲劳的两个重要方面,即其严重程度和慢性程度,通常未得到评估。本研究调查了荷兰全国队列中CCS 中严重慢性疲劳(CF)的患病率和危险因素。
本研究纳入了 2810 名 CCS(1963 年至 2001 年间诊断的所有儿童恶性肿瘤的 5 年幸存者,当前年龄为 12-65 岁)和 1040 名兄弟姐妹对照者。使用简短疲劳问卷评估 CF,将得分≥18 分且疲劳持续≥6 个月定义为 CF。通过多变量逻辑回归分析评估癌症和治疗相关特征、当前健康问题以及人口统计学和生活方式变量作为 CF 的潜在危险因素。
在成年 CCS 和兄弟姐妹对照者(≥18 岁)中,CF 的患病率分别为 26.1%和 14.1%(P<0.001)。在青少年 CCS 和兄弟姐妹对照者(<18 岁)中,CF 的患病率分别为 10.9%和 3.2%。女性(比值比 [OR],2.13;95%置信区间 [CI],1.73-2.62)、失业(OR,2.18;95% CI,1.67-2.85)、存在 1 种或多种健康问题(存在 1-2 种健康问题的 OR,1.48;95% CI,1.18-1.87;存在>2 种健康问题的 OR,2.20;95% CI,1.50-3.21)和中枢神经系统诊断(OR,1.74;95% CI,1.17-2.60)与成年 CCS 中的 CF 显著相关。
本研究表明,CCS 无论其癌症诊断如何,报告 CF 的频率均高于兄弟姐妹对照者。本研究为 CCS 中疲劳的患病率提供了新的证据。